FDA Approves Atypical Antipsychotic Aristada

[SzAdmin]

Yes - more info here. This is basically identical to Abilify Maintena.

New Long Acting Injection Abilify / Aripiprazole ( Alkermes Aristada) Approved by FDA

Federal regulators this week approved a new schizophrenia drug from Alkermes PLC, an Irish biotech company with executives based at its Waltham campus. The drug, Aristada, is a long-acting version of Abilify, a best-selling antipsychotic that earned more than $9 billion worldwide last year, according to IMS Health, before losing patent protection in April. Administered by injection, Aristada dissolves slowly over four to six weeks, negating the need for daily pill-taking. As many as half of schizophrenia patients on oral antipsychotics don’t end up taking their medications as prescribed. “Long-acting medications to treat schizophrenia can improve the lives of patients,” said Mitchell Math…